Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
Titel:
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
Auteur:
Maucher, Isabelle V. Rühl, Michael Kretschmer, Simon B.M. Hofmann, Bettina Kühn, Benjamin Fettel, Jasmin Vogel, Anja Flügel, Karsten T. Manolikakes, Georg Hellmuth, Nadine Häfner, Ann-Kathrin Golghalyani, Vahid Ball, Ann-Katrin Piesche, Matthias Matrone, Carmela Geisslinger, Gerd Parnham, Michael J. Karas, Michael Steinhilber, Dieter Roos, Jessica Maier, Thorsten J.